Helena Rönnqvist, Francesco Mazzotta, Annamaja Segtnan and Per Nilsson, got the idea for the product under the auspices of CTMH’s Clinical Innovation Fellowship programme.
Per Nilsson, Annamaja Segtnan, Francesco Mazzotta and Helena Rönnqvist got the idea for the product under the auspices of CTMH’s Clinical Innovation Fellowship programme. This is home to multi-talented teams, needed in everyday healthcare, who can develop innovative products and services.
“We’d never have met had it not been for the Fellowships programme because there are not many opportunities for people with such different professional backgrounds to meet. At the same time, the development of new medical technologies needs a growing number of skill sets if it is to be successful,” says Francesco Mazzotta.
Among the factors that are set to give Pilloxa the edge over competitors is its holistic approach to e-health, its own patent, and a substantially lower price point compared to existing products. As well as a smoother, more user-friendly interface.
“The best dosette packaging is one that you use. Our goal has therefore been to develop a product that feels easy, intuitive and easy to carry around. Neither should it be stigmatising by signalling illness,” says Helena Rönnqvist, a doctor.
In the early stages of the product’s development, the team conducted a series of interviews to identify potential user requirements.
“We quickly realised that customers lacked a well designed product that suited an active lifestyle, along with being smartphone-compatible,” explains Annamaja Segtnan, industrial designer.
Patients given greater responsibility
An entire spectrum of customers has been identified, from the young to the elderly, tech-savvy adults, as well as parents of children who regularly take medication.
“The latter group will follow their childrens’ medication, but give the children the opportunity of taking responsibility for their own medication. This is easy with our product,” says Nilsson.
When daily care becomes increasingly patient-centric, a growing degree of responsibility lies with patients in their contact with healthcare providers, the team believes.
“A full 30 per cent of those who go to accident and emergency do so as the result of issues related to medication. We have tried to create a product that gives patients – young and old – better control of their medication,” says Rönnqvist.
Coaching by Flemingsberg Science
The company has received funding from, among others, SLL Innovation, Vinnova, KTH Innovation, Almi and Nordic Innovation. Flemingsberg Science became involved at an early stage by providing a business coach.
“It’s been great to have been able to trust someone whose business experience is more extensive than your own. Flemingsberg Science has given us a framework that maps out which steps we need to take and when we should take them. As well as the opportunity to see potential development issues early so that we can avoid them,” says Nilsson.
The product is scheduled for launch towards the end of the year. A clinical study of the product is also planned next year at Karolinska University Hospital.
“We want to demonstrate that our product genuinely contributes to improved clinical outcomes,” says Nilsson.
Launching in 2016, Pilloxa’s smart dosette packaging uses a smartphone app to ensure that medication is taken on time; it also provides access to personal drug information, and can be connected to other similar e-health products and services.